Bio-Rad Labs: Things are changing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio-Rad Labs: Things are changing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave Chanoux who wrote (3)	2/10/2000 9:32:00 PM
From: Dave Chanoux	Read Replies (1) of 18

Fourth Quarter and Full Year results released today. "Pain oh piercing pain, how yea doth trouble me..." Bio-Rad Laboratories, Inc. announced today that sales for the year totaled $549.5 million, reflecting an increase of more than 24% over 1998 year-end results. For the fourth quarter, total sales were $194.4 million, an increase of 64% over the fourth quarter of 1998. Net income for 1999 was $11.7 million ($.97 per share), compared to $24.3 million ($1.98 per share) for 1998. The fourth quarter net loss was $11.2 million ($.92 per share). These results reflect Bio-Rad's recent acquisition of Pasteur Sanofi Diagnostics (PSD) which was finalized on October 1, 1999. Well the incremental revenue generated a loss alright. Is this ever going to get profitable?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next